Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $25.06 -5.93%
Revenue Growth %: -23.8%
Financial Fact:
Total operating expenses: 36.9M
Today's EPS Names:
LTBR, AES, SYRS, More
Revenue Growth %: -23.8%
Financial Fact:
Total operating expenses: 36.9M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.43), $0.02 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $37.9 million versus the consensus estimate of $36.7 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- ONE Gas (OGS) Tops Q3 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Inspire Medical Systems (INSP) Tops Q3 EPS by 5c, Beats on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
